COVID-19 test kit

SARS-COV-2influenza Ainfluenza B

OPTI Medical Systems has obtained US FDA Emergency Use Authorization and CE marking for its OPTI* SARS-CoV-2/Influenza A/B RT-PCR Test for identification and differentiation of SARS-CoV-2, influenza A, and influenza B RNA. This respiratory panel distinguishes between SARS-CoV-2, influenza A and influenza B extracted from nasopharyngeal swabs. Use of this test is ideal for identifying the cause of symptoms during influenza season. Distinguish between COVID-19 and flu Multiplexed detection and differentiation of three viruses simultaneously. Validated on common PCR instruments: Applied Biosystems* 7500, QuantStudio* 5, Roche LightCycler* 480 II, Bio-Rad CFX96 Touch*, Bio Molecular Systems Mic qPCR Cycler. Detection of two different targets in the N coding region of SARS-CoV-2, avoiding the S mutations found in recent variants. Monitoring of new variants of SARS-CoV-2 to ensure the test is not impacted by viral mutations. Optimized workflow from start to finish using an internal sample control targeting human RNase P. Combine this test with the OPTI* DNA/RNA Magnetic Bead Kit for a complete solution.